Technical Analysis for OGEN - Oragenics, Inc.

Grade Last Price % Change Price Change
F 0.27 -5.18% -0.01
OGEN closed up 2.86 percent on Wednesday, November 20, 2024, on 38 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
NR7 Range Contraction -5.17%
Narrow Range Bar Range Contraction -5.17%
Inside Day Range Contraction -5.17%
Wide Bands Range Expansion -5.17%
Gapped Up Strength -5.17%
Oversold Stochastic Weakness -5.17%
New 52 Week Closing Low Bearish -2.46%
Lower Bollinger Band Walk Weakness -2.46%
New 52 Week Low Weakness -2.46%
Stochastic Reached Oversold Weakness -2.46%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 2 hours ago
60 Minute Opening Range Breakout about 2 hours ago
Up 1% about 3 hours ago
Lower Bollinger Band Support about 4 hours ago
Down 5% about 4 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Oragenics, Inc. Description

Oragenics, Inc., a healthcare company, engages in the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits in the United States and internationally. It develops ProBiora3, an oral care probiotics technology for oral health, teeth whitening, and breath freshening for humans and pets. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus for daily use by adults and EvoraKids for daily use by children after brushing their teeth; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a professional strength version of EvoraPlus. Its product pipeline consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. The company was founded in 1996 and is headquartered in Tampa, Florida.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Health Care Antibiotics Pet Dog Various Technologies Bacteriology Digestive System Weight Loss Oral Hygiene Probiotics

Is OGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.74
52 Week Low 0.2542
Average Volume 525,964
200-Day Moving Average 1.24
50-Day Moving Average 0.37
20-Day Moving Average 0.32
10-Day Moving Average 0.33
Average True Range 0.04
RSI (14) 37.11
ADX 17.08
+DI 19.59
-DI 24.65
Chandelier Exit (Long, 3 ATRs) 0.31
Chandelier Exit (Short, 3 ATRs) 0.38
Upper Bollinger Bands 0.37
Lower Bollinger Band 0.27
Percent B (%b) 0.18
BandWidth 32.44
MACD Line -0.03
MACD Signal Line -0.03
MACD Histogram 0.0022
Fundamentals Value
Market Cap 887.24 Thousand
Num Shares 3.08 Million
EPS -4.60
Price-to-Earnings (P/E) Ratio -0.06
Price-to-Sales 324.82
Price-to-Book 2.49
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.31
Resistance 3 (R3) 0.31 0.30 0.30
Resistance 2 (R2) 0.30 0.30 0.30 0.30
Resistance 1 (R1) 0.29 0.29 0.29 0.29 0.30
Pivot Point 0.29 0.29 0.29 0.29 0.29
Support 1 (S1) 0.28 0.28 0.28 0.28 0.27
Support 2 (S2) 0.27 0.28 0.27 0.27
Support 3 (S3) 0.27 0.27 0.27
Support 4 (S4) 0.27